Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4336 | 1729 | 51.1 | 91% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
395 | 16247 | CYTOCHROME P450//CYP2D6//PREGNANE X RECEPTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PREGNANE X RECEPTOR | Author keyword | 208 | 68% | 10% | 181 |
2 | PXR | Author keyword | 143 | 59% | 9% | 161 |
3 | CONSTITUTIVE ANDROSTANE RECEPTOR | Author keyword | 139 | 75% | 6% | 101 |
4 | PHARMACOGENET SECT | Address | 43 | 38% | 5% | 90 |
5 | PREGNANE X RECEPTOR PXR | Author keyword | 26 | 69% | 1% | 22 |
6 | HPXR | Author keyword | 20 | 100% | 1% | 9 |
7 | CONSTITUTIVE ANDROSTANE RECEPTOR CAR | Author keyword | 19 | 68% | 1% | 17 |
8 | REPROD DEV TOXICOL | Address | 16 | 16% | 5% | 93 |
9 | CAR | Author keyword | 16 | 15% | 6% | 99 |
10 | NR1I3 | Author keyword | 11 | 78% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PREGNANE X RECEPTOR | 208 | 68% | 10% | 181 | Search PREGNANE+X+RECEPTOR | Search PREGNANE+X+RECEPTOR |
2 | PXR | 143 | 59% | 9% | 161 | Search PXR | Search PXR |
3 | CONSTITUTIVE ANDROSTANE RECEPTOR | 139 | 75% | 6% | 101 | Search CONSTITUTIVE+ANDROSTANE+RECEPTOR | Search CONSTITUTIVE+ANDROSTANE+RECEPTOR |
4 | PREGNANE X RECEPTOR PXR | 26 | 69% | 1% | 22 | Search PREGNANE+X+RECEPTOR+PXR | Search PREGNANE+X+RECEPTOR+PXR |
5 | HPXR | 20 | 100% | 1% | 9 | Search HPXR | Search HPXR |
6 | CONSTITUTIVE ANDROSTANE RECEPTOR CAR | 19 | 68% | 1% | 17 | Search CONSTITUTIVE+ANDROSTANE+RECEPTOR+CAR | Search CONSTITUTIVE+ANDROSTANE+RECEPTOR+CAR |
7 | CAR | 16 | 15% | 6% | 99 | Search CAR | Search CAR |
8 | NR1I3 | 11 | 78% | 0% | 7 | Search NR1I3 | Search NR1I3 |
9 | XENOBIOTIC RECEPTOR | 9 | 67% | 0% | 8 | Search XENOBIOTIC+RECEPTOR | Search XENOBIOTIC+RECEPTOR |
10 | CYP2B | 9 | 29% | 1% | 25 | Search CYP2B | Search CYP2B |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CONSTITUTIVE ANDROSTANE RECEPTOR | 334 | 46% | 31% | 541 |
2 | PREGNANE X RECEPTOR | 287 | 35% | 38% | 658 |
3 | XENOBIOTIC RECEPTOR | 266 | 81% | 9% | 158 |
4 | PXR | 225 | 69% | 11% | 190 |
5 | ENHANCER MODULE | 162 | 80% | 6% | 99 |
6 | CYP3A4 GENE EXPRESSION | 128 | 87% | 4% | 62 |
7 | RESPONSIVE ENHANCER MODULE | 102 | 85% | 3% | 53 |
8 | CYP2B GENE | 93 | 80% | 3% | 57 |
9 | DISTAL ENHANCER MODULE | 73 | 85% | 2% | 39 |
10 | XENOBIOTIC RESPONSE | 70 | 78% | 3% | 46 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond | 2013 | 23 | 134 | 72% |
Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator | 2014 | 17 | 104 | 31% |
Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters | 2012 | 55 | 255 | 51% |
Targeting xenobiotic receptors PXR and CAR in human diseases | 2015 | 1 | 95 | 82% |
Signaling control of the constitutive androstane receptor (CAR) | 2014 | 4 | 92 | 85% |
Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR | 2010 | 71 | 172 | 66% |
Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects | 2009 | 104 | 289 | 60% |
Deciphering the roles of the constitutive androstane receptor in energy metabolism | 2015 | 1 | 111 | 68% |
Targeting xenobiotic receptors PXR and CAR for metabolic diseases | 2012 | 26 | 71 | 73% |
Role of CAR and PXR in xenobiotic sensing and metabolism | 2012 | 23 | 129 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACOGENET SECT | 43 | 38% | 5.2% | 90 |
2 | REPROD DEV TOXICOL | 16 | 16% | 5.4% | 93 |
3 | NUCL RECEPTOR DISCOVERY | 7 | 32% | 1.0% | 18 |
4 | PL PHARMACEUT EDUC | 5 | 55% | 0.3% | 6 |
5 | DRUG METAB MOL TOXICOL | 4 | 16% | 1.3% | 23 |
6 | PHARMACOL NEUROBIOL | 3 | 13% | 1.3% | 22 |
7 | U632 | 3 | 21% | 0.8% | 13 |
8 | BIOSCI SUPPORT | 3 | 60% | 0.2% | 3 |
9 | UNIDAD HEPATOL EXPT | 3 | 13% | 1.0% | 18 |
10 | PHARMACODYNAM MOL GENET | 2 | 32% | 0.3% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000207491 | PHARMACOEPIGENETICS//ALFRED MED EDUC PROJECT//BANDUNG HOSP |
2 | 0.0000123278 | PHARMACOKINET BIOANAL//CYP2D19//PROPRANOLOL ENANTIOMER |
3 | 0.0000116203 | CYP3A//COCKTAIL//MECHANISM BASED INHIBITION |
4 | 0.0000106798 | CYP2C12//ONE DAY TREATMENT//S BIOCHEM |
5 | 0.0000085002 | FARNESOID X RECEPTOR//FXR//TGR5 |
6 | 0.0000074232 | ROLLINS 5119//ANTIPYRINE PHARMACOKINETICS//CYTOCHROME P4502B1 2 |
7 | 0.0000072847 | CONAZOLES//ZEBRAFISH EMBRYOTOXICITY TEST//TRIADIMEFON |
8 | 0.0000066843 | EFAVIRENZ//CYP2B6//NEVIRAPINE |
9 | 0.0000064566 | CYP1B1//CYP2S1//CYTOCHROME P4501B1 |
10 | 0.0000061929 | CYTOKINE BIOL SIGNAL TRANSDUCT//MICROGLIAL INFLAMMATION//MOUTH CLEANING |